← All organizations
Highest phase reached
Phase 4
First clinical trial
Oct 31, 2021Last known activity
Aug 22, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (38 distinct, 19 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 3 (12 own, 0 via acquisition)
Phase 2 (9 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (8 own, 0 via acquisition)
Recent trials (29)
- NCT07136519Sponsor investigatorPhase 2Aug 22, 2025
- NCT07136519Lead sponsorPhase 2Aug 22, 2025
- NCT06940960Lead sponsorN/AMay 30, 2025
- NCT06940960Sponsor investigatorN/AMay 30, 2025
- NCT06904183CollaboratorPhase 2Apr 1, 2025
- NCT06763666CollaboratorPhase 4Feb 28, 2025
- NCT06712888CollaboratorPhase 3Jan 1, 2025
- NCT06526455Lead sponsorPhase 4Aug 1, 2024
- NCT06526455Sponsor investigatorPhase 4Aug 1, 2024
- NCT06462313CollaboratorN/AJul 22, 2024
- NCT06125756Reponsible party - principal investigatorEarly Phase 1Dec 20, 2023
- NCT06125756Overall official - principal investigatorEarly Phase 1Dec 20, 2023
- NCT06125756Lead sponsorEarly Phase 1Dec 20, 2023
- NCT06117657Overall official - principal investigatorEarly Phase 1Nov 10, 2023
- NCT06117657Reponsible party - principal investigatorEarly Phase 1Nov 10, 2023
Details
- Last known activity
- Aug 22, 2025